ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer.

Benjamin Solomon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.